These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
845 related articles for article (PubMed ID: 20705131)
21. Immune Endophenotypes in Children With Autism Spectrum Disorder. Careaga M; Rogers S; Hansen RL; Amaral DG; Van de Water J; Ashwood P Biol Psychiatry; 2017 Mar; 81(5):434-441. PubMed ID: 26493496 [TBL] [Abstract][Full Text] [Related]
22. Detection of plasma autoantibodies to brain tissue in young children with and without autism spectrum disorders. Rossi CC; Van de Water J; Rogers SJ; Amaral DG Brain Behav Immun; 2011 Aug; 25(6):1123-35. PubMed ID: 21420487 [TBL] [Abstract][Full Text] [Related]
23. Neonatal Cytokine Profiles Associated With Autism Spectrum Disorder. Krakowiak P; Goines PE; Tancredi DJ; Ashwood P; Hansen RL; Hertz-Picciotto I; Van de Water J Biol Psychiatry; 2017 Mar; 81(5):442-451. PubMed ID: 26392128 [TBL] [Abstract][Full Text] [Related]
27. Myeloid dendritic cells frequencies are increased in children with autism spectrum disorder and associated with amygdala volume and repetitive behaviors. Breece E; Paciotti B; Nordahl CW; Ozonoff S; Van de Water JA; Rogers SJ; Amaral D; Ashwood P Brain Behav Immun; 2013 Jul; 31():69-75. PubMed ID: 23063420 [TBL] [Abstract][Full Text] [Related]
28. Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 4 Years - Early Autism and Developmental Disabilities Monitoring Network, Seven Sites, United States, 2010, 2012, and 2014. Christensen DL; Maenner MJ; Bilder D; Constantino JN; Daniels J; Durkin MS; Fitzgerald RT; Kurzius-Spencer M; Pettygrove SD; Robinson C; Shenouda J; White T; Zahorodny W; Pazol K; Dietz P MMWR Surveill Summ; 2019 Apr; 68(2):1-19. PubMed ID: 30973853 [TBL] [Abstract][Full Text] [Related]
29. Integrative analysis of γδT cells and dietary factors reveals predictive values for autism spectrum disorder in children. Zhang L; Xu Y; Sun S; Liang C; Li W; Li H; Zhang X; Pang D; Li M; Li H; Lang Y; Liu J; Jiang S; Shi X; Li B; Yang Y; Wang Y; Li Z; Song C; Duan G; Leavenworth JW; Wang X; Zhu C Brain Behav Immun; 2023 Jul; 111():76-89. PubMed ID: 37011865 [TBL] [Abstract][Full Text] [Related]
30. Serum cytokine levels in children with spectrum autism disorder: Differences in pro- and anti-inflammatory balance. Kordulewska NK; Kostyra E; Piskorz-Ogórek K; Moszyńska M; Cieślińska A; Fiedorowicz E; Jarmołowska B J Neuroimmunol; 2019 Dec; 337():577066. PubMed ID: 31629288 [TBL] [Abstract][Full Text] [Related]
31. Parent-reported and clinician-observed autism spectrum disorder (ASD) symptoms in children with attention deficit/hyperactivity disorder (ADHD): implications for practice under DSM-5. Grzadzinski R; Dick C; Lord C; Bishop S Mol Autism; 2016; 7():7. PubMed ID: 26788284 [TBL] [Abstract][Full Text] [Related]
32. Maternal immune-mediated conditions, autism spectrum disorders, and developmental delay. Lyall K; Ashwood P; Van de Water J; Hertz-Picciotto I J Autism Dev Disord; 2014 Jul; 44(7):1546-55. PubMed ID: 24337796 [TBL] [Abstract][Full Text] [Related]
33. Self representation in children with and without Autism Spectrum Disorders. Carmody DP; Lewis M Child Psychiatry Hum Dev; 2012 Apr; 43(2):227-37. PubMed ID: 22011811 [TBL] [Abstract][Full Text] [Related]
34. The effect of DSM-5 criteria on externalizing, internalizing, behavioral and adaptive symptoms in children diagnosed with autism. Turygin NC; Matson JL; Adams H; Belva B Dev Neurorehabil; 2013 Aug; 16(4):277-82. PubMed ID: 23617257 [TBL] [Abstract][Full Text] [Related]
35. Elevated IL-16 expression is associated with development of immune dysfunction in children with autism. Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Al-Ayadhi LY; Attia SM Psychopharmacology (Berl); 2019 Feb; 236(2):831-838. PubMed ID: 30456538 [TBL] [Abstract][Full Text] [Related]
36. "Autism-plus" spectrum disorders: intersection with psychosis and the schizophrenia spectrum. Cochran DM; Dvir Y; Frazier JA Child Adolesc Psychiatr Clin N Am; 2013 Oct; 22(4):609-27. PubMed ID: 24012076 [TBL] [Abstract][Full Text] [Related]
37. Cytokine levels and associations with symptom severity in male and female children with autism spectrum disorder. Masi A; Breen EJ; Alvares GA; Glozier N; Hickie IB; Hunt A; Hui J; Beilby J; Ravine D; Wray J; Whitehouse AJO; Guastella AJ Mol Autism; 2017; 8():63. PubMed ID: 29214007 [TBL] [Abstract][Full Text] [Related]
38. Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes. Ashwood P; Enstrom A; Krakowiak P; Hertz-Picciotto I; Hansen RL; Croen LA; Ozonoff S; Pessah IN; Van de Water J J Neuroimmunol; 2008 Nov; 204(1-2):149-53. PubMed ID: 18762342 [TBL] [Abstract][Full Text] [Related]
39. Immunological and autoimmune considerations of Autism Spectrum Disorders. Gesundheit B; Rosenzweig JP; Naor D; Lerer B; Zachor DA; Procházka V; Melamed M; Kristt DA; Steinberg A; Shulman C; Hwang P; Koren G; Walfisch A; Passweg JR; Snowden JA; Tamouza R; Leboyer M; Farge-Bancel D; Ashwood P J Autoimmun; 2013 Aug; 44():1-7. PubMed ID: 23867105 [TBL] [Abstract][Full Text] [Related]
40. Neonatal cytokines and chemokines and risk of Autism Spectrum Disorder: the Early Markers for Autism (EMA) study: a case-control study. Zerbo O; Yoshida C; Grether JK; Van de Water J; Ashwood P; Delorenze GN; Hansen RL; Kharrazi M; Croen LA J Neuroinflammation; 2014 Jun; 11():113. PubMed ID: 24951035 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]